COVID-19 and the liver: an adverse outcome pathway perspective
Sign Up to like & getrecommendations! Published in 2021 at "Toxicology"
DOI: 10.1016/j.tox.2021.152765
Abstract: Liver damage is observed in up to half of hospitalized COVID-19 patients and can result either from actions of SARS-CoV-2 as such or from pharmacological treatment. The present paper introduces an adverse outcome pathway construct… read more here.
Keywords: adverse outcome; covid liver; outcome pathway; pathway perspective ... See more keywords